10 diagnostics reimbursement experts

Payer strategy and market access titles make up most of this group of diagnostics reimbursement experts, at Myriad Genetics, Natera, BillionToOne, Octave and Belay Diagnostics, while Patricia Petrucci, Stephen Reynolds and Natalie Thurston hold billing or revenue cycle roles at Adaptive Biotechnologies, Biotheranostics and NavDx. That split suits a lab deciding how to win first coverage and codes for a new test, or how to fix denials and collections once billing starts.

10 professionals8 companiesData retrieved September 28, 2026

Professionals to explore

  1. Barbara M.

    LinkedIn

    Experience: Senior Director, Strategic Reimbursement · NeoGenomics Laboratories

    Barbara M. has been Senior Director, Strategic Reimbursement at NeoGenomics Laboratories since 2016 and lists specialties in reimbursement and government affairs, state healthcare legislation, medical policy, CMS and MACs, technology assessments and coding, coverage and reimbursement. Earlier titles include Global Director, Reimbursement, Healthcare Economics and Health Policy, Neuromodulation Division at St. Jude Medical (2013-2016) and Senior Director, Reimbursement Affairs, Government Healthcare Policy & Accreditation at Biomet (1994-2011), a fit for Medicare coverage questions.

    Is this you? Claim your profile and get paid for calls.

  2. Brian Belle

    LinkedIn

    Experience: Former Senior Vice President, Payer Strategy & Reimbursement · Myriad Genetics

    Brian Belle became Senior Vice President, Payer Strategy & Reimbursement at Myriad Genetics in 2026, after Vice President, National Payer Markets (2021-2026), Director, Payer Markets and Reimbursement (2018-2021) and Senior Regional Account Manager (2013-2018) there. Brian describes over 24 years in pharmaceutical and molecular diagnostics with partnerships with managed care organizations and government accounts, a good match for national payer contracting questions.

    Is this you? Claim your profile and get paid for calls.

  3. Carrie McGehee

    LinkedIn

    Experience: Former Vice President of Health Economics, Outcomes and Reimbursement · Pathnostics - A Diagnostics Solutions Company

    Carrie McGehee has been VP of Market Access at BillionToOne since 2021, after Vice President of Health Economics, Outcomes and Reimbursement at Pathnostics - A Diagnostics Solutions Company (2019-2021). Carrie also held Vice President of Managed Care titles at Alliance Family of Companies (2018-2019) and Applied Proteomics, Inc. (2016-2018) and VP Managed Care and Reimbursement at Caris Life Sciences (2016), relevant for payer relations planning.

    Is this you? Claim your profile and get paid for calls.

  4. Debbie Stephens Ledet

    LinkedIn

    Experience: Former Head of Market Access & Reimbursement · NeoGenomics Laboratories

    Debbie Stephens Ledet has been Chief Access Officer at Octave since 2024 and was Head of Market Access & Reimbursement at NeoGenomics Laboratories (2023-2024), Chief Access Officer at Perspectum Ltd (2021-2023) and Senior Director, Global Market Access at Natera (2014-2016). In Debbie's own words, the work is to secure CPT codes, reimbursement, medical policy coverage and commercial and governmental contracts, so coding and coverage questions fit well.

    Is this you? Claim your profile and get paid for calls.

  5. Devki Saraiya Nagar

    LinkedIn

    Experience: Former Director - Payer Markets and Reimbursement · Myriad Genetics

    At Myriad Genetics, Devki Saraiya Nagar has been Vice President, Payer Markets since February 2026, and earlier held Medical Policy Specialist (2014), Regional Account Manager (2014-2018), Director - Payer Markets and Reimbursement (2018-2024) and Sr. Director - Market Access (2024-2026). Devki describes 11+ years shaping reimbursement and payer policy across precision medicine, oncology, women's health and mental health, and building clear payer value stories, which suits questions on building a payer value story.

    Is this you? Claim your profile and get paid for calls.

  6. Donna Polizio

    LinkedIn

    Experience: Former VP, Managed Care and Reimbursement · Genomic Health

    Donna Polizio is Head of Strategy, Market Access at Natera (since 2025), after Global Head of Market Access at Bionano (2022-2025), VP Market Access at Exact Sciences (2019-2022) and VP, Managed Care and Reimbursement at Genomic Health (2011-2019). Donna was also Director of Reimbursement at RedPath Integrated Pathology (2010-2011), which makes Donna a fit for market access strategy questions.

    Is this you? Claim your profile and get paid for calls.

  7. Jerry Conway

    LinkedIn

    Experience: Former VP of Reimbursement & Payer Strategy · Foundation Medicine

    Jerry Conway has been Senior Vice President of Market Access at Belay Diagnostics since 2024 and held the same title at GeneDx (2022-2023) and Scipher Medicine (2019-2022). Jerry was also Executive Vice President at CDx Diagnostics (2018-2019) and VP of Reimbursement & Payer Strategy at Foundation Medicine (2012-2018), useful for building a payer strategy from launch.

    Is this you? Claim your profile and get paid for calls.

  8. Natalie Thurston, RN, MBA

    LinkedIn

    Experience: Vice President Reimbursement · NavDx

    Natalie Thurston, RN, MBA is Vice President Reimbursement (since 2025) and Senior Director RCM and Payer Engagement (since 2023) at NavDx, and places the role at Naveris, Inc., which develops highly sensitive blood tests that identify viral cancers earlier than scans or traditional biopsies. Natalie was Senior Director Reimbursement Strategic Operations at Lucid Diagnostics (2023) and has consulted at Aledo Consulting and Thurston Consulting since 2016, relevant for reimbursement on a new blood-based cancer test.

    Is this you? Claim your profile and get paid for calls.

  9. Patricia Petrucci

    LinkedIn

    Experience: Senior Director Reimbursement · Adaptive Biotechnologies Corp.

    Patricia Petrucci oversees and manages the billing and reimbursement functions for Adaptive's CLIA lab service as Senior Director Reimbursement at Adaptive Biotechnologies Corp. (since 2025), working with physicians, payers and patients. Patricia was Senior Director Billing Operations at CDx Diagnostics Inc. (2018-2025), Senior Director, Revenue Cycle Management at Bio Reference Laboratories Inc - GeneDx (2015-2018) and Director, Accounts Receivable at BioReference (2013-2015), so lab billing and collections questions fit well.

    Is this you? Claim your profile and get paid for calls.

  10. Stephen Reynolds

    LinkedIn

    Experience: Sr. Director of Reimbursement Revenue Cycle Management · Biotheranostics, Inc., A Hologic Company

    Stephen Reynolds is Sr. Director of Reimbursement Revenue Cycle Management at Biotheranostics, Inc., A Hologic Company (since 2016), after Director of Reimbursement Managed Care at Pathway Genomics Corporation (2015). Stephen describes knowledge of the medical billing and reimbursement process and billing software, including compliance, CCI, OIG regulations, MolDx and CMS, a fit for billing compliance questions.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For coverage strategy on a new test, Debbie Stephens Ledet describes securing CPT codes and medical policy coverage, and Devki Saraiya Nagar and Donna Polizio hold or held payer and market access titles at Myriad Genetics, Natera, Exact Sciences and Genomic Health; Barbara M. lists CMS and MAC work and technology assessments. For claims, billing and collections, Patricia Petrucci and Stephen Reynolds are the closest match, with Stephen citing MolDx and CMS compliance.

Questions to take into the conversation

  1. 01How do you sequence a MolDX technical assessment, a code application and commercial payer outreach for a new test?
  2. 02What evidence persuades a commercial payer's medical policy team to cover a test before guidelines include it?
  3. 03Which claim denials for a lab test are worth appealing, and how do you staff that appeals work?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Diagnostics